Related Experiment Video
Updated: Jun 26, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Antibiotic-associated Gut Dysbiosis
Balakrishnan S Ramakrishna1, Roy Patankar2
1Director and Senior Consultant Gastroenterologist, SRM Institutes for Medical Science, Vadapalani, Chennai, Tamil Nadu, India, Corresponding Author.
Antibiotics disrupt the gut microbiota, causing dysbiosis and impacting health. Strategies like probiotics and fecal microbiota transplantation (FMT) can help restore microbial balance.
Area of Science:
- Microbiology
- Pharmacology
- Gastroenterology
Background:
- The human gut microbiota is essential for health.
- Antibiotic use can disrupt this delicate microbial ecosystem.
- Gut dysbiosis, an imbalance in the microbiota, is a growing concern.
Purpose of the Study:
- To review the relationship between antibiotics and gut dysbiosis.
- To explore the mechanisms of antibiotic-induced microbiota disruption.
- To discuss implications for human health and mitigation strategies.
Main Methods:
- Literature review of studies on antibiotics and gut microbiota.
- Analysis of mechanisms causing microbial imbalance.
- Evaluation of therapeutic interventions for dysbiosis.
Main Results:
- Antibiotics reduce microbial diversity and alter metabolite production.
- Broad-spectrum antibiotics cause more severe dysbiosis than narrow-spectrum ones.
- Dysbiosis is linked to various health disorders.
Conclusions:
- Antibiotic-associated gut dysbiosis has significant health implications.
- Probiotics, fecal microbiota transplantation (FMT), and phage therapy show promise in restoring gut microbiota balance.
- Further research is needed to optimize these interventions.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...